Skip to content
★ Sign in to follow
NW

Nanjing Well Pharmaceutical Group Co.,Ltd. Stock: price and insider trades · China

威尔药业

CN·Mcap CN¥3.6BHealth Care

Nanjing Well Pharmaceutical Group Co.,Ltd.: what insiders have been doing

Nanjing Well Pharmaceutical Group Co.,Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Nanjing Well Pharmaceutical Group Co.,Ltd. The previous disclosure was published on 24 March 2023.

Over the whole record (from 2021), the tally stands at no purchases and 3 sales.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€819,071
3 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 11,344 of 26,897 companies
55.6
score / 100
Value
54
Quality
57
FCF yld5.2%
Earn yld4.2%
EV/EBITDA13.2x
ROE8.7%
Gross mgn28%
Net mgn11%
Debt/EBITDA1.8x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥26.61
Analyst consensus
·
Income statement
RevenueCN¥1.3B
Gross profitCN¥380M28% margin
EBITDACN¥316M24% margin
Net incomeCN¥151M11.1% margin
Valuation
PER (trailing)23.5x
P/Book2.0x
Beta0.32
Balance sheet & cash
Market capCN¥3.6B
Total debtCN¥574.7M
Free Cash FlowCN¥186.1M
Debt / Equity23%
Profitability & ownership
ROE8.7%
ROA4.6%
% insiders61.5%
% institutions5.5%
Last declaration on 24 March 2023
Declarations3 total
  • ▼
    董事,高级管理人员Executives
    1M CNY15SSE
    50,000 shares100.0% of flowA股XSHGSSE:173000006396974750
  • ▼
    高级管理人员Executives
    297,000 CNY19SSE
    12,500 shares100.0% of flowA股XSHGSSE:173000006201828060
  • ▼
    监事Executives
    4M CNY15SSE
    115,300 shares100.0% of flowA股XSHGSSE:173000005190207780

3 of 3 declarations

About Nanjing Well Pharmaceutical Group Co.,Ltd.

威尔药业 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and marketing of innovative pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations